Literature DB >> 7995192

Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases.

N Arber1, F M Konikoff, M Moshkowitz, M Baratz, A Hallak, M Santo, Z Halpern, H Weiss, T Gilat.   

Abstract

One hundred twenty-three patients with chronic liver diseases of various etiologies were evaluated for their iron status. The patients were divided into four distinct groups: chronic hepatitis C (63), chronic hepatitis B (14), B + C (3) and nonviral chronic liver diseases (43). In 107 patients (87%) the chronic liver disease was confirmed by biopsy. Mean serum iron (+/- SD) levels in the above four groups were: 166 +/- 62, 103 +/- 52, 142 +/- 48, and 115 micrograms/dl; iron-binding capacity was 346 +/- 80, 325 +/- 72, 297 +/- 27, and 374 +/- 75 micrograms/dl, and iron saturation 50 +/- 18, 32 +/- 16, 48 +/- 16, and 28 +/- 10%, respectively. Serum ferritin, increased in all four groups, was highest in HCV; however, no evidence of hepatic iron accumulation could be found in any of the patients. There were no significant differences in liver function parameters measured in the four groups. We conclude that serum iron, iron saturation, and ferritin are increased in patients with hepatitis C in comparison to hepatitis B or other nonviral, nonhemochromatotic liver diseases. The increased iron status in hepatitis C patients is not manifested by increased liver iron. Awareness of these distinct features of chronic hepatitis C is essential in the diagnosis and treatment of chronic liver diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995192     DOI: 10.1007/BF02087705

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred.

Authors:  J W Rowe; J R Wands; E Mezey; L A Waterbury; J R Wright; J Tobin; R Andres
Journal:  Medicine (Baltimore)       Date:  1977-05       Impact factor: 1.889

2.  Measurements of iron status in patients with chronic hepatitis.

Authors:  A M Di Bisceglie; C A Axiotis; J H Hoofnagle; B R Bacon
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

3.  Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release.

Authors:  A M Konijn; C Hershko
Journal:  Br J Haematol       Date:  1977-09       Impact factor: 6.998

Review 4.  New developments in diagnostic liver pathology.

Authors:  K G Ishak
Journal:  Monogr Pathol       Date:  1987

Review 5.  Iron and infection.

Authors:  C Hershko; T E Peto; D J Weatherall
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05

Review 6.  Role of the liver in normal iron metabolism.

Authors:  B R Bacon; A S Tavill
Journal:  Semin Liver Dis       Date:  1984-08       Impact factor: 6.115

7.  Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis.

Authors:  R W Chapman; M Y Morgan; M Laulicht; A V Hoffbrand; S Sherlock
Journal:  Dig Dis Sci       Date:  1982-10       Impact factor: 3.199

8.  Placental type isoferritins in chronic liver diseases.

Authors:  F Konikoff; Y Shoenfeld; D A Isenberg; F Theodor; C Moroz
Journal:  Hepatogastroenterology       Date:  1987-04

9.  Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C.

Authors:  R Pérez; R Pravia; A Linares; M Rodríguez; J L Lombraña; A Suárez; S Riestra; C A Navascués; L Rodrigo
Journal:  Gut       Date:  1993       Impact factor: 23.059

10.  Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection.

Authors:  N Arber; M Moshkowitz; F Konikoff; Z Halpern; A Hallak; M Santo; E Tiomny; M Baratz; T Gilat
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

View more
  12 in total

Review 1.  [1997 gastroenterology update--II].

Authors:  W Fischbach; V Gross; J Schölmerich; C Ell; P Layer; W E Fleig
Journal:  Med Klin (Munich)       Date:  1998-03-15

2.  Iron, HCV and the liver.

Authors:  K P Maier
Journal:  World J Gastroenterol       Date:  1997-06-15       Impact factor: 5.742

Review 3.  Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.

Authors:  H L Bonkovsky; J V Obando
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

4.  Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.

Authors:  Wei-Hong Hou; Lisa Rossi; Ying Shan; Jian-Yu Zheng; Richard-W Lambrecht; Herbert-L Bonkovsky
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

5.  Increased oxidative stress, decreased total antioxidant capacity, and iron overload in untreated patients with chronic hepatitis C.

Authors:  Danielle Venturini; Andréa Name Colado Simão; Décio Sabbatini Barbosa; Edson Lopes Lavado; Victor Emanuel Soares Narciso; Isaias Dichi; Jane Bandeira Dichi
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

6.  Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B.

Authors:  Shogo Ohkoshi; Akira Yoshimura; Satoshi Yamamoto; Masahiko Yano; So Kurita; Kazuhide Yamazaki; Yo-Hei Aoki; Satoshi Yamagiwa; Hiroto Wakabayashi; Motoya Sugiyama; Tohru Takahashi; Tohru Ishikawa; Yasunobu Matsuda; Takafumi Ichida; Tomoteru Kamimura; Yutaka Aoyagi
Journal:  Hepatol Int       Date:  2008-07-25       Impact factor: 6.047

Review 7.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

8.  Hyperferritinemia is a risk factor for steatosis in chronic liver disease.

Authors:  Anna Licata; Maria Elena Nebbia; Giuseppe Cabibbo; Giovanna Lo Iacono; Francesco Barbaria; Virna Brucato; Nicola Alessi; Salvatore Porrovecchio; Vito Di Marco; Antonio Craxì; Calogero Cammà
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

9.  Iron, hepcidin and inflammatory status of young healthy overweight and obese women in Australia.

Authors:  Hoi Lun Cheng; Christian E Bryant; Kieron B Rooney; Katharine S Steinbeck; Hayley J Griffin; Peter Petocz; Helen T O'Connor
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

10.  Haplotype Analysis of Hemochromatosis Gene Polymorphisms in Chronic Hepatitis C Virus Infection: A Case Control Study.

Authors:  Sina Gerayli; Alireza Pasdar; Mohammad Taghi Shakeri; Samaneh Sepahi; Seyed Mousalreza Hoseini; Mitra Ahadi; Sina Rostami; Zahra Meshkat
Journal:  Iran Red Crescent Med J       Date:  2016-05-15       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.